tiprankstipranks
Advertisement
Advertisement

Teva sees Austedo sales greater than $2.5B in 2027

Reaffirms 2025 Ajovy revenue outlook $630M-$640M. Sees ~$700M in net savings by 2027, with two thirds of savings expected to be realized by 2026. Comments taken from investor presentation slides.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1